Buprenorphine hydrochloride
Pro Research Analysisby 
Searched over 200M research papers for "buprenorphine hydrochloride"
Buprenorphine Hydrochloride: Clinical Applications and Efficacy
Buprenorphine Hydrochloride for Opioid Dependence Treatment
Comparison with Extended-Release Naltrexone
Buprenorphine hydrochloride, often combined with naloxone, is a widely used treatment for opioid dependence. A study comparing daily buprenorphine-naloxone with extended-release naltrexone found that both treatments were similarly effective in maintaining short-term abstinence from heroin and other illicit substances. The trial, conducted over 12 weeks, showed no significant difference in the proportion of opioid-negative urine drug tests between the two groups, indicating that buprenorphine-naloxone is a viable option for opioid-dependent individuals .
Subcutaneous Depot Formulations
Recent advancements have introduced weekly and monthly subcutaneous depot formulations of buprenorphine, which have shown noninferiority to daily sublingual buprenorphine-naloxone. These depot formulations not only maintained similar efficacy in terms of opioid-negative urine samples but also demonstrated superior results in cumulative distribution function analysis, suggesting potential advantages in sustained-release formulations for opioid use disorder treatment .
Rapid Dose Induction
A rapid dose induction procedure for buprenorphine hydrochloride has been evaluated, showing that ascending daily doses up to 8 mg are well-tolerated by heroin-dependent individuals. This method resulted in increased feelings of well-being and reduced withdrawal symptoms, making it an effective and acceptable approach for transitioning from heroin to buprenorphine treatment .
Analgesic Effects in Veterinary Medicine
American Kestrels and Cockatiels
Buprenorphine hydrochloride has been studied for its analgesic effects in various avian species. In American kestrels, intramuscular administration of buprenorphine at doses of 0.1, 0.3, and 0.6 mg/kg increased thermal antinociceptive thresholds for up to 6 hours, indicating effective pain relief without significant adverse effects . However, in cockatiels, similar doses did not significantly alter thermal nociceptive thresholds, suggesting species-specific responses to buprenorphine .
New Zealand White Rabbits
In New Zealand White rabbits, a compounded sustained-release formulation of buprenorphine provided effective postoperative analgesia comparable to regular buprenorphine. This sustained-release formulation, administered subcutaneously, offers a promising alternative for improving animal welfare by reducing the frequency of dosing and maintaining consistent analgesic effects .
Cellular and Biochemical Effects
Apoptosis in Nerve Cells
Buprenorphine hydrochloride has been shown to induce apoptosis in NG108-15 nerve cells. This effect is characterized by DNA fragmentation and morphological changes, occurring within 4 hours of administration. The apoptosis is dose-dependent and involves a specific serine protease in the death-signal cascade, highlighting a potential cellular mechanism of action for buprenorphine .
Conclusion
Buprenorphine hydrochloride is a versatile medication with significant applications in both human and veterinary medicine. Its efficacy in treating opioid dependence, particularly with new sustained-release formulations, and its analgesic properties in various animal species underscore its clinical importance. Further research into its cellular effects and optimization of delivery methods will continue to enhance its therapeutic potential.
Sources and full results
Most relevant research papers on this topic
Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder: A Randomized Clinical Trial
Weekly and monthly subcutaneous buprenorphine depot formulations are noninferior to daily sublingual buprenorphine with naloxone in treating opioid use disorder.
Evaluation of thermal antinociceptive effects after intramuscular administration of buprenorphine hydrochloride to American kestrels (Falco sparverius).
Buprenorphine hydrochloride, at doses tested, increased thermal threshold in American kestrels for at least 6 hours, suggesting analgesic effects in this species.
Chemiluminescence determination of bufrenorphine hydrochloride by flow injection analysis
This flow-injection method is a rapid, simple, and accurate method for determining buprenorphine hydrochloride, with a limit of detection of 1 108 M and linear calibration up to 1 104 M.
Simultaneous Transdermal Delivery of Buprenorphine Hydrochloride and Naltrexone Hydrochloride by Iontophoresis.
Iontophoresis is a feasible approach for controlled delivery of naltrexone and buprenorphine hydrochloride through the skin, potentially improving addiction treatment.
Buprenorphine for the treatment of opioid dependence.
Buprenorphine is an effective treatment for opioid dependence, but improving compliance and adherence are crucial for its widespread use.
DOI